A global biopharma focused on severe diseases in three therapeutic areas:
Central nervous system
Inflammation
Oncology
UCB also has a selective presence in primary care
Global revenue of €3.6 billion in 2007
Operations in over 40 countries, supported by more than 10,000 staff
Established in 1928, successful transformation from a hybrid specialty chemical company into a next generation biopharma leader
Listed on the Euronext Brussels Stock Exchange
Headquartered in Brussels, Belgium
Total Jobs: 4
View All "UCB Pharmaceuticals, Inc." Jobs
